Precision medicine in cystic fibrosis: predictive role of forskolin-induced swelling assay.

Autor: Furstova E; Department of Paediatrics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic., Drevinek P; Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic pavel.drevinek@lfmotol.cuni.cz., Novotna S; Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic., Libik M; Department of Biology and Medical Genetics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic., Benesova K; Department of Clinical Psychology, Motol University Hospital, Prague, Czech Republic.; Department of Neurology and Centre for Clinical Neuroscience, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic., Borek-Dohalska L; Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic., Sakmarova K; Department of Bioinformatics, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic., Modrak M; Department of Bioinformatics, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic., Macek M Jr; Department of Biology and Medical Genetics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic., Dousova T; Department of Paediatrics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
Jazyk: angličtina
Zdroj: The European respiratory journal [Eur Respir J] 2024 Apr 18; Vol. 63 (4). Date of Electronic Publication: 2024 Apr 18 (Print Publication: 2024).
DOI: 10.1183/13993003.00156-2024
Abstrakt: Competing Interests: Conflict of interest: P. Drevinek declares honoraria for lectures from Vertex Pharmaceuticals and Chiesi CZ, and participation on advisory boards for Vertex Pharmaceuticals and Viatris, all in the 36 months prior to manuscript submission, and is the president of the Czech Society for Medical Microbiology. M. Macek Jr declares consulting fees from Devyser.com and Vertex Pharmaceuticals, and support for attending the European Cystic Fibrosis Conference from Chiesi Pharmaceuticals, all in the 36 months prior to manuscript submission. The remaining authors have no potential conflicts of interest to disclose.
Databáze: MEDLINE